Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04428151
Brief Title: Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

First Submitted : June 9, 2020
First Submitted that Met QC Criteria : June 9, 2020
First Posted : June 11, 2020

Last Update Submitted that Met QC Criteria : November 25, 2021
Last Update Posted : November 29, 2021